Skip to Content

'
Thomas A. Buchholz, M.D., F.A.C.R.

Present Title & Affiliation

Primary Appointment

Department Chair, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Frank T. McGraw Memorial Chair in the Study of Cancer, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Professor (tenure), Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1988 Tufts University School of Medicine, Boston, MA, MD, Medicine
1984 Bucknell University, Lewisburg, PA, BA, Philosophy

Postgraduate Training

1/2005-12/2005 Faculty Leadership Training, The University of Texas M. D. Anderson Cancer Center, Houston, TX
7/1992-6/1993 Research Fellowship, Radiobiology Research, University of Washington Medical Center, Seattle, WA, George E. Laramore, M.D., Ph.D., Janet S. Rasey, P
7/1989-6/1992 Clinical Residency, Radiation Oncology, University of Washington Medical Center, Seattle, WA, Wui-Jin Koh, M.D.
7/1988-6/1989 Clinical Internship, Medical Internship, Mount Auburn Hospital, Cambridge, MA, Charles Hatem, M.D.

Board Certifications

6/1993 American Board of Radiology (Radiation Oncology)
1/1989 National Board of Medical Examiners

Honors and Awards

2008-present Fellow, American College of Radiology, American College of Radiology
2003-2010 Top Doctors in America, Castle Connolly Medical Ltd

Selected Publications

Peer-Reviewed Original Research Articles
1. Wang X, Yu TK, Salehpour M, Zhang SX, Sun TL, Buchholz TA. Breast Cancer Regional Radiation Fields for Supraclavicular and Axillary Lymph Node Treatment: Is a Posterior Axillary Boost Field Technique Optimal? Int J Radiat Oncol Biol Phys 74(1). e-Pub 9/2009. PMID: 18805650.
2. Smith BD, Smith GL, Roberts KB, Buchholz TA. Baseline utilization of breast radiotherapy prior to Institution of the Medicare Practice Quality Reporting Initiative. Int J Radiat Oncol Biol Phys 74(5):1506-12, 8/1/2009. e-Pub 4/22/2009. PMID: 19395182.
3. Smith GL, Smith BD, Gardes AS, Rosenthal DI, Sherman SI, Morrison WH, Schwartz DL, Weber RS, Buchholz TA. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study. Head Neck 31(8):1031-8, 8/2009. e-Pub 4/2009. PMID: 19360741.
4. Smith BD, Arthur D, Buchholz T, Haffty B, Hahn C, Hardenbergh P, Julian T, Marks L, Todor D, Vicini F, Whelan T, White J, Wo J, Harris J. Accelerated partial breast irradiation consensus statement from the American Society for radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74(4):987-1001, 7/15/2009. PMID: 19545784.
5. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TA. Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer. Am J Surg Pathol 33(5):759-67, 5/2009. e-Pub 2/2009. PMID: 19252432.
6. Shih T, Xu Y, Cormier J, Giordano SH, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a two-year follow-up study. J Clin Oncol 27(12):2007-2014, 4/2009. e-Pub 3/16/2009. PMID: 19289624.
7. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH. The impact of pregnancy on breast cancer outcomes in women </=35 years. Cancer 115(6):1174-84, 3/2009. PMID: 19204903.
8. Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, Moran JM, Pierce LJ, Rabinovitch R, Taghian A, Vicini F, Woodward W, White JR, White JR. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys 73(3):944-51, 3/2009. PMID: 19215827.
9. Garg AK, Frija EK, Sun TL, Strom EA, Perkins GH, Oh JL, Yu TK, Woodward WA, Tereffe WA, Salehpour M, Buchholz TA. Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breast and supraclavicular radiotherapy. Int J Radiat Oncol Biol Phys 73(2):370-4, 2/2009. PMID: 18676090.
10. Loya A, guray M, Hennessy BT, Middleton LP. Buchholz TA, Valero V, Sahin AA. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer 115(8):1605-12, 2/2009. e-Pub 2/5/2009. PMID: 19197997.
11. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JA. Coexpression of {alpha}6{beta}4 Integrin and Guanine Nucleotide Exchange Factor Net1 Identifies Node-Positive Breast Cancer Patients at High Risk for Distant Metastasis. Cancer Epidemiol Biomarkers Prev 18(1):80-6, 1/2009. PMID: 19124484.
12. Buchholz TA. Radiation therapy in the management of early-stage breast cancer after breast-conserving surgery. N Engl J Med 360(1):63-70, 1/2009. PMID: 19118305.
13. Kronowitz SJ, Kuerer HM, Buchholz TA, Valero V, Hunt KK. A management algorithm and practical oncoplastic surgical techniques to repair partial mastectomy defects. Plat Reconstr Surg 122(6):1631-1647, 12/2008. PMID: 19050516.
14. Ballo MT, Postma KE, Washington CM, Buchholz TA, Cox JD. Development of a successful outreach program at M. D. Anderson Cancer Center: a global perspective. J Am Coll Radiol 5(12):1170-1173, 12/2008. PMID: 19027677.
15. Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJ. Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin Cancer Res 14(23):7909-7916, 12/2008. PMID: 19047121.
16. Dawood S, Broglio K, Kau SW, Green MC, Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT, Hennessy BT, Hortobagyi GN, Gonzalez-Angulo AM. Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol 27(2). e-Pub 12/2008. PMID: 19047281.
17. Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL, Bernstein JL. Dose to the Contralateral Breast from Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study. Int J Radiat Oncol Biol Phys 72(4):1021-1030, 11/2008. e-Pub 6/14/2008. PMID: 18556141.
18. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Local-regional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 10/1/2008. e-Pub 4/2008. PMID: 18439768.
19. Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, Oh JL, Yu TK, Bedrosian I, Whitman GJ, Buchholz TA, Dong L. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. Int J Radiat Oncol Biol Phys 73(5):1493-500, 9/17/2008. e-Pub 9/17/2008. PMID: 18804333.
20. Smith GL, Smith BD, Buchholz TA, Giordano SH, Garden AS, Woodward WA, Krumholz HM, Weber RS, Ang KK, Rosenthal DI. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol 26(31):5119-25, 8/25/2008. e-Pub 8/25/2008. PMID: 18725647.
21. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 8/14/2008. e-Pub 8/2008. PMID: 18707822.
22. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Staging of breast cancer in the neoadjuvant setting. Cancer Res 68(16):6477-6481, 8/2008. PMID: 18701468.
23. Wang X, Du W, Smith SA, Stoval M, Buchholz TA, Salehpour M. The radiation exposure from portal images during the course of breast radiotherapy. Am J Clin Oncol 31(4):345-351, 8/2008. PMID: 18845993.
24. Srokowski TP, Fang S, Duan Z, Buchholz TA, Hortobagyi GN, Goodwin JS, Giordano SH. Completion of adjuvant radiation therapy among women with breast cancer. Cancer 113(1):22-9, 7/1/2008. e-Pub 4/2008. PMID: 18442124.
25. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and 1-3 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 7/15/2008. PMID: 18234447.
26. Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WA. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed based on the anatomical distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 71(2):435-440, 6/2008. PMID: 18164831.
27. Dawood S, Broglio K, Gong Y, Yang WT, Cristofanilli M, Kau SW, Meric-Bernstam F, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Gonzalez-Angulo AM. Prognostic significance of HER2 status in women with inflammatory breast cancer. Cancer 112(9):1905-11, 5/1/2008. e-Pub 2/2008. PMID: 18300243.
28. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 71(1):226-236, 5/2008. PMID: 18406887.
29. Smith BD, Haffty BG, Smith GL, Hurria A, Buchholz TA, Gross CP. Use of post-mastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys 71(1):98-106, 5/2008. PMID: 17996393.
30. Smith GL, Smith BD, Giordano SH, Shih YT, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-1379, 3/2008. PMID: 18213620.
31. Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, Miller MJ, Whelan T, Pierce LJ, Esserman LJ, Newman LA, Smith BL, Bear HD, Mamounas EP. Statement of the science concerning loco-regional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute Conference. J Clin Oncol 26(5):791-797, 2/2008. PMID: 18258988.
32. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26(2):246-252, 1/2008. e-Pub 12/2007. PMID: 18056680.
33. Dawood S, Broglio K, Kau SW, Symmans WF, Buchholz TA, McGuire SE, Meric F, Cristofanilli M, Hortobagyi GN, Gonzalez-Angulo AM. Prognostic value of initial clinical disease stage after achieving pathological complete response. Oncologist 13(1):6-15, 1/2008. PMID: 18245008.
34. Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Youssef A, Koutz CA, Robb GL. Practical guidelines for the breast reduction technique for repair of partial mastectomy defects in patients undergoing breast conservation therapy. Plastic Reconstructive Surg 120(7):1755-1768, 12/2007. PMID: 18090737.
35. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-2427, 11/2007. e-Pub 10/2007. PMID: 17941034.
36. Woodward WA, Durand JB, Tucker SL, Strom EA, Perkins GH, Oh JL, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid flow in breast cancer patients treated with supraclavicular irradiation eight or more years prior to study: No increase in ipsilateral carotid stenosis after radiation. Cancer 112(2):268-273, 11/2007. PMID: 18000801.
37. Liengsawangwong R, Yu TK, Sun TL, Erasmus J, Perkins GH, Tereffe W, Oh JL, Woodward WA, Strom EA, Salehpour M, Buchholz TA. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 69(3):711-715, 11/2007. PMID: 17889264.
38. Cristofanilli M, Valero V, Buzdar AU, Kau SW, Broglio KR, Gonzalez-Angulo AM, Islam R, Hortobagyi GN, Sneige N, Ueno NT, Buchholz TA, Singletary SE. Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease. Cancer 110(7):1436-1444, 10/2007. PMID: 17694554.
39. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans, WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-531, 10/2007. PMID: 17826073.
40. Garg AK, Oh JL, Oswald MJ, Huang E, Strom EA, Perkins GH, Hahn K, Buchholz TA. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Rad Oncol Biol Phys 69:1478-1483, 9/2007. PMID: 17855016.
41. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Genetic variants in the promoter region of H2AX are associated with risk of sporadic breast cancer in non-Hispanic white women 55 years. Breast Cancer Res Treat 110(2):357-66, 9/2007. PMID: 17851762.
42. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low local-regional failure rates in selected breast cancer patients with tumor-positive sentinel nodes who do not undergo completion axillary dissection. Cancer 110(4):723-730, 8/2007. PMID: 17587208.
43. Gonzalez-Angulo MA, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobagyi GN. Trends for inflammatory breast cancer: Is survival improving? Oncologist 12(8):904-912, 8/2007. PMID: 17766649.
44. McGuire SE, Gonzalez-Angulo AM, Tucker SL, Kau SW, Yu Tk, Strom EA, Oh J, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin A, Hortobagyi GN, Buchholz TA. Post-mastectomy radiation improves the outcome of patients with stage III breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-1009, 7/2007. PMID: 17418973.
45. Mazouni C, Kau SW, Frye D, Andre F, Kuerer HM, Buchholz TA, Symmans WF, Anderson K, Hess KR, Gonzales-Angulo AM, Hortobagyi GN, Buzdar AU, Pusztai L. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in ER-positive breast cancers. Ann Oncol 18(5):874-880, 5/2007. e-Pub 2/2007. PMID: 17293601.
46. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, Buchholz TA. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: An analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 68(1):59-65, 5/2007. PMID: 17321065.
47. Wiedenmann N, Valdecanas D, Hunter N, Hyde S, Buchholz TA, Milas L, Mason KA. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain. Clin Cancer Res 13(6):1868-1874, 3/2007. PMID: 17363543.
48. Borghero YO, Salehpour M, McNeese MD, Stovall M, Smith SA, Johnson J, Perkins GH, Strom EA, Oh JL, Kirsner SM, Woodward WA, Yu TK, Buchholz TA. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: A phantom model comparison. Radiother Oncol 82(3):324-328, 3/2007. PMID: 17157944.
49. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2/1/2007. PMID: 17236970.
50. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Local-regional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Rad Oncol Biol Phys 67(2):490-496, 2/2007.
51. Chen MS, Woodward WA, Behbod F, Peddibhotla S, Alfaro MP, Buchholz TA, Rosen JM. Wnt/(beta)-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci 120(3):468-477, 2/2007.
52. Cabioglu N, Hunt KK, Sahin A, Mirza N, Lopez A, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA. Intraoperative margin assessment for breast-conserving surgery. Ann Surg Oncol 14(4):1458-1471, 1/2007. e-Pub 1/2007. PMID: 17260108.
53. Buzdar AU, Valero V, Ibrahim NK, Francis D, Broglio KR, Theriault RL, Pusztai L, Green MC, Singletary SE, Hunt KK, Sahin AA, Esteva F, Symmans WF, Ewer MS, Buchholz TA, Hortobagyi GN. Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res 13(1):228-33, 1/2007. PMID: 17200359.
54. Woodward WA, Chen MS, Behbod F, Mohsin S, Alfaro MP, Kittrel F, Buchholz TA, Rosen JM. Wnt/B-catenin-mediated radiation resistance of mouse mammary stem-like/progenitor cells. Proc Nat Acad Sciences 104(2):618-623, 1/2007.
55. Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Middleton L, Gwyn K, Hortobagyi GN, Buchholz TA. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer 107(11):2662-2668, 12/2006.
56. Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TA. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol 24:4971-5, 11/2006. PMID: 17075114.
57. Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 203:64-72, 7/2006. PMID: 16798488.
58. Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer 106:2556-62, 6/2006. PMID: 16691617.
59. Motwani SB, Strom EA, Schechter NR, Butler CE, Lee GK, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Ibrahim NK, Buchholz TA. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 66(1):76-82, 6/2006. PMID: 16765534.
60. Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh J, Domain D, Yu TK, Woodward WA, Tereffe W, Singletary SE, Thomas E, Buzdar AU, Hortobagyi GN, McNeese MD. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 65:1155-60, 5/2006. PMID: 16750325.
61. Ueno NT, Konoplev S, Buchholz TA, Smith T, Rondon G, Anderlini P, Giralt SA, Gajewski JL, Donato ML, Cristofanilli M, Champlin RE. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy. Bone Marrow Transplant 37:929-35, 5/2006. PMID: 16565737.
62. Oh JL, Bonnen M, Outlaw ED, Schechter NR, Perkins GH, Strom EA, Babiera G, Oswald MJ, Allen PK, Thames HD, Buchholz TA. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"? Int J Radiat Oncol Biol Phys 65(5):1345-52, 5/2006. PMID: 16750315.
63. Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA, Babiera G, Hortobagyi GN, Valero V. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 17:605-13, 4/2006. PMID: 16469754.
64. Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol 24:361-9, 1/2006. PMID: 16421417.
65. Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Rad Oncol Biol Phys 66:352-7, 2006.
66. Kassas B, Mourtada F, Horton JL, Lane RG, Buchholz TA, Strom EA. Dose modification factors for 192lr high-dose-rate irradiation using Monte Carlo simulations. J Appl Clin Med Phys 7(3):28-34, 2006.
67. Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 106:42-50, 2006. PMID: 16333852.
68. Floyd SR, Buchholz TA, Haffty BG, Goldberg S, Niemierko A, Raad RA, Oswald MJ, Sullivan T, Strom EA, Powell SN, Katz A, Taghian AG. Low local recurrence rate without post-mastectomy radiation in node-negative breast cancer patients with tumors 5cm and larger. Int J Rad Oncol Biol Phys 66:358-64, 2006.
69. Vo T, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK. Outcomes of breast conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192:552-5, 2006.
70. Rivera E, Meyers C, Groves M, Brewster A, Giordano S, Murray JL, Valero V, Francis D, Arun B, Broglio K, Yin G, Hortobagyi GN, Buchholz TA. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107:1348-54, 2006.
71. Guarneri V, Broglio K, Kau SW, Cristofanilli M, Buzdar AU, Valero V, Buchholz TA, Meric F, Middleton L, Hortobagyi GN, Gonzales-Angulo AM. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. J Clin Oncol 24:1037-44, 2006.
72. Smith BD, Haffty BG, Buchholz TA, Smith GL, Galusha DH, Bekelman JE, Gross CP. Risk of in situ or invasive relapse and mastectomy in older women with ductal carcinoma in situ. J Nat Cancer Inst 98:1302-10, 2006.

Last updated: 9/22/2009